MIT Technology Review August 6, 2022
Hana Kiros

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

Fifteen years ago, David Glowacki was walking in the mountains when he took a sharp fall. When he hit the ground, blood began leaking into his lungs. As he lay there suffocating, Glowacki’s field of perception swelled. He peered down at his own body—and, instead of his typical form, saw that he was made up of balled-up light.

“I knew that the intensity of the light was related to the extent to which I inhabited my body,” he recalls. Yet watching it dim didn’t frighten him. From his new vantage point, Glowacki could see that the light wasn’t disappearing....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Metaverse/VR, Provider, Technology
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired
FDA initiative puts AR/VR at heart of home health drive
Meta's Reality Labs posts $3.85 billion loss in first quarter
Meta Aims to Ignite Enterprise Productivity With Open Metaverse OS

Share This Article